*Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ
Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery
Molecular Therapy: Methods & Clinical Development
(2017), doi: 10.1016/j.omtm.2017.04.006